COVID-19 vaccine development built on $17 billion in NIH funding for vaccine technologies

India’s COVID-19 surge and the new variant: what we know
22 April 2021
A new method for fighting ‘cold’ tumors
22 April 2021

COVID-19 vaccine development built on $17 billion in NIH funding for vaccine technologies

The unprecedented development of COVID-19 vaccines less than a year after discovery of this virus was enabled by more than $17 billion of research on vaccine technologies funded by the NIH prior to the pandemic, according to new research from Bentley University’s Center for Integration of Science and Industry. The article, titled “NIH funding for vaccine readiness before the COVID-19 pandemic,” demonstrates the critical role this broad foundation of government-funded research plays in ensuring vaccine readiness.

Comments are closed.